This is a clinical, randomised, double-blinded study in which patients eligible for aortic valve replacement are enrolled. Patients receive infusion of either levosimendan or placebo 4 hours prior to surgery and until the end of surgery.
Levosimendan or placebo will be infusion for approximately 4 hours prior to aortic valve replacement in patients with severe hypertrophy of the left ventricle and echocardiographic signs of diastolic dysfunction. Outcome measures will be obtained at some of the following: * Approximately 4 hours prior to surgery. Baseline. Start of levosimendan/placebo infusion * Immediately before surgery * After induction of anaesthesia and before "knife time" = start of surgery. * At the end of surgery: Levosimendan infusion will stop. * Approximately 4 hours after surgery immediately before extubation. * Approximately 21 hours after surgery * Approximately 96 hours after surgery (day 4) * 6 months after surgery Outcome measures are comprised of invasive measurements, blood samples, transthoracic echocardiography and transoesophageal echocardiography focusing on measures of systolic and diastolic function of the heart. Interim analysis will be conducted after 30 included patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
20
Intravenous infusion, 0,1ug/kg/min, duration 4 hours prior to operation and until the end of operation.
Intravenous infusion, colour identical to levosimendan
Department of Anaesthesiology
Århus N, Central Jutland, Denmark
E/E'(Unitless)
Ration between early transmitral flow (E) and mitral annular tissue velocity(E'). This ratio is an echocardiographic index of diastolic function
Time frame: 4 hours before operation until 21 hour after operation
Isovolumetric Relaxation Time (IVRT) (s)
Transthoracic measure of the time from aortic valve closure until mitral valve opening. A measure of diastolic function
Time frame: 4 hours before surgery until 1 hour before operation
Ejection Fraction (Per Cent)
Transeosophageal echocardiography: Measure of systolic function
Time frame: At start of operation until end of operation, approximately 3 hours
Cardiac Index (l/Min/m2)
Invasive measurement measuring the cardiac output divided by calculated body surface area (DuBois formula)
Time frame: 4 hours before operation until 1 hour before operation
Central Venous Pressure (mmHg)
Invasive measurement of pressure in the vena cava
Time frame: 4 hours before operation until 1 hours before operation
Pulmonary Artery Pressures (mmHg)
Invasive measurement of mean pressure in the pulmonary artery
Time frame: 4 hours before operation until 1 hour before operation
Systemic Arterial Pressure (mmHg)
Invasive measurements of arterial mean pressure
Time frame: 4 hours before operation until 1 hour before operation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
N-terminal Pro Brain Natriuretic Peptide (NT proBNP)(pg/ml)
blood sample reflecting stretch of the atrium/ventricle
Time frame: 4 hours before operation until 4 hours after operation
Troponin T (ug/l)
Blood sample expressing damage to the myocytes
Time frame: 4 hours before operation until 4 hours after operation
Lactate (mmol/l)
Arterial sampling of blood lactate
Time frame: 4 hours before operation until 4 hour after operation
Mixed Venous Oxygenation (Per Cent)
Oxygen content (per cent of hemoglobin saturated) of venous blood in pulmonary artery
Time frame: 4 hours before operation until 4 hour after operation
E/A Ratio (Unitless)
TEE ratio between early (E) transmitral flow and late (A) transmitral flow. An index of diastolic function althought not validated properly yet when measured from the oesophagus
Time frame: At the start of operation until the end of operationon, approximately 3 hours
Regional Longitudinal Strain (Unitless)
Transoesophageal echocardiographic (TEE) measure of systolic function. At this time not validated properly against acknowledged indices of systolic function.
Time frame: At the start of operation until the end of operation, approximately 3 hours
Need for Conventional Inotropical Agents
Conventional inotropics are comprised of all inotropics acting primarily through alfa- or beta- stimulation.
Time frame: From start of operation until 5 days after operation
Intravenous Fluid Requirement (l)
Total volume of intravenous fluid required including blood products.
Time frame: Within 24 hours from start of operation
Operation Time (Minutes)
Time frame: From "knife start" until "knife end", approximately 3 hours
Time on Heart-lung Machine (Minutes)
Time frame: From time of cardioplegia until selfsufficient cardiac action, approximately 1 hour
Intubation Time (Minutes)
Total time intubated including time of operation and in the intensive care ward
Time frame: From intubation until extubation, approximately 6 hours
Postoperative Admission Time at Intensive Care Unit (Hours)
Total admission time in the intensive care after operation
Time frame: From admission to the intensive care unit until discharge from intensive care unit, approximately 24 hours
No. of Patients With Adverse Events
Development of Ventricular tachycardia
Time frame: -4 hours until + 96 hours with respect to start of operation
No. of Patients With Adverse Event
Development of atrial flutter/fibrillation
Time frame: -4 hours until + 96 hours with respect to start of operation
No. of Patients With Adverse Event
Need for norepinephrine as an antagonist to the vasodilatatory effect of levosimendan
Time frame: 4 hours before operaton until 1 hour before operaton
No. of Patients With Adverse Event.
Occurence of nausea
Time frame: 4 hours before operation until 1 hour before operation
No. of Patients With Adverse Event
Occurence of headache
Time frame: 4 hours before operation until approximately 1 hour before operation
Regional Longitudinal Strain (Unitless)
Index of systolic function derived from single transthoracic echocardiographic (TTE) projection
Time frame: 4 hours before until 1 hour before start of operation
Ejection Fraction (Per Cent)
TTE: Index of systolic function
Time frame: 1 hour before until 21 hour after start of operation
Ejection Fraction (Per Cent)
TTE: Index of systolic function
Time frame: 21 hours after operation until 96 hours after start of operation
Ejection Fraction (Per Cent)
TTE: Index of systolic function
Time frame: 96 hours after operation until 6 months after operation
Regional Longitudinal Strain (Unitless)
Transoesophageal echocardiographic (TEE) measure of systolic function. At this time not validated properly against acknowledged indices of systolic function.
Time frame: Froml the end of operation until approx 4 hours after operation
E/A Ratio (Unitless)
TEE ratio between early (E) transmitral flow and late (A) transmitral flow. An index of diastolic function althought not validated properly yet when measured from the oesophagus
Time frame: At the end of operationon until approx 4 hours after operation
Left Ventricular Rotation (Degrees)
TTE: Index of both systolic and diastolic function
Time frame: 96 hour after operation until 6 months after operation
Mixed Venous Oxygenation (Per Cent)
Oxygen content (per cent of hemoglobin saturated) of venous blood in pulmonary artery
Time frame: 4 hours after operation until 21 hours after operation
Lactate (mmol/l)
Arterial sampling of blood lactate
Time frame: 4 hours after operation until 21 hours after operation
Troponin T (ug/l)
Blood sample expressing damage to the myocytes
Time frame: 4 hours after operation until 21 hours after operation
Troponin T (ug/l)
Blood sample expressing damage to the myocytes
Time frame: 21 hours after operation until 96 hours after operation
N-terminal Pro Brain Natriuretic Peptide (NT proBNP)(pg/ml)
blood sample reflecting stretch of the atrium/ventricle
Time frame: 4 hours after operation until 21 hours after operation
N-terminal Pro Brain Natriuretic Peptide (NT proBNP)(pg/ml)
blood sample reflecting stretch of the atrium/ventricle
Time frame: 21 hours after operation until 96 hours after operation
Systemic Arterial Pressure (mmHg)
Invasive measurements of arterial mean pressure
Time frame: 1 hour before operation until start of operation
Systemic Arterial Pressure (mmHg)
Invasive measurements of arterial mean pressure
Time frame: Start of operation until the end of operation, approximately 3 hours
Systemic Arterial Pressure (mmHg)
Invasive measurements of arterial mean pressure
Time frame: End of operation until approx 4 hours after operation
Systemic Arterial Pressure (mmHg)
Invasive measurements of arterial mean pressure
Time frame: 4 hours after operation until 21 hours after operation
Pulmonary Artery Pressures (mmHg)
Invasive measurement of mean pressure in the pulmonary artery
Time frame: 1 hour before operation until start of operation
Pulmonary Artery Pressures (mmHg)
Invasive measurement of mean pressure in the pulmonary artery
Time frame: Start of operation until end of operation, approximately 3 hours
Pulmonary Artery Pressures (mmHg)
Invasive measurement of mean pressure in the pulmonary artery
Time frame: End of operation until approx 4 hours after operation
Pulmonary Artery Pressures (mmHg)
Invasive measurement of mean pressure in the pulmonary artery
Time frame: 4 hours after operation until 21 hours after operation
Regional Longitudinal Strain (Unitless)
Index of systolic function derived from single transthoracic echocardiographic (TTE) projection
Time frame: 1 hour before start of operation until 21 hours after operation
Regional Longitudinal Strain (Unitless)
Index of systolic function derived from single transthoracic echocardiographic (TTE) projection
Time frame: 21 hours after operation until 96 hours after operation
Regional Longitudinal Strain (Unitless)
Index of systolic function derived from single transthoracic echocardiographic (TTE) projection
Time frame: 96 hours after operation until 6 months after operation
Central Venous Pressure (mmHg)
Invasive measurement of pressure in the vena cava
Time frame: 1 hour before operation until start of operation
Central Venous Pressure (mmHg)
Invasive measurement of pressure in the vena cava
Time frame: Start of operation until end of operation, approximately 3 hours
Central Venous Pressure (mmHg)
Invasive measurement of pressure in the vena cava
Time frame: End of operation until approx 4 hours after operation
Central Venous Pressure (mmHg)
Invasive measurement of pressure in the vena cava
Time frame: 4 hours after operation until 21 hours after operation
Peak Systolic Velocity (m/s)
Tissue Doppler measure of systolic function
Time frame: 1 hour before operation until 21 hours after operation
Peak Systolic Velocity (m/s)
Tissue Doppler measure of systolic function
Time frame: 21 hours after operation until 96 hours after operation
Peak Systolic Velocity (m/s)
Tissue Doppler measure of systolic function
Time frame: 96 hours after operation until 6 months after operation
Tricuspid Annular Plane Systolic Excursion (TAPSE) (mm)
Transthoracic echocardiographic measure of systolic function
Time frame: 1 hour before operation until 21 hours after operation
Tricuspid Annular Plane Systolic Excursion (TAPSE) (mm)
Transthoracic echocardiographic measure of systolic function
Time frame: 21 hours after operation until 96 hours after operation
Tricuspid Annular Plane Systolic Excursion (TAPSE) (mm)
Transthoracic echocardiographic measure of systolic function
Time frame: 96 hours after operation until 6 months after operation
E/A-ratio (Unitless)
Transthoracic echocardiographic ratio between early (E) and late (A) transmitral blood velocities. Index of diastolic function.
Time frame: 1 hour before operation until 21 hours after operation
E/A-ratio (Unitless)
Transthoracic echocardiographic ratio between early (E) and late (A) transmitral blood velocities. Index of diastolic function.
Time frame: 21 hours after operation until 96 hours after operation
E/A-ratio (Unitless)
Transthoracic echocardiographic ratio between early (E) and late (A) transmitral blood velocities. Index of diastolic function.
Time frame: 96 hours after operation until 6 months after operation
E'/A'-Ratio (Unitless)
Tissue Doppler transthoracic echocardiography: Ratio between tissue velocities at the mitral plan during early (E) diastole and late (A) diastole. Index of diastolic function.
Time frame: 1 hour before operation until 21 hours after roperation
E'/A'-Ratio (Unitless)
Tissue Doppler transthoracic echocardiography: Ratio between tissue velocities at the mitral plan during early (E) diastole and late (A) diastole. Index of diastolic function.
Time frame: 21 hours after operation until 96 hours after operation
E'/A'-Ratio (Unitless)
Tissue Doppler transthoracic echocardiography: Ratio between tissue velocities at the mitral plan during early (E) diastole and late (A) diastole. Index of diastolic function.
Time frame: 96 hours after operation until 6 months after operation
Isovolumetric Relaxation Time (IVRT) (s)
Transthoracic measure of the time from aortic valve closure until mitral valve opening. A measure of diastolic function
Time frame: 1 hour before operation until 21 hours after operation
Isovolumetric Relaxation Time (IVRT) (s)
Transthoracic measure of the time from aortic valve closure until mitral valve opening. A measure of diastolic function
Time frame: 21 hours after operation until 96 hours after operation
Isovolumetric Relaxation Time (IVRT) (s)
Transthoracic measure of the time from aortic valve closure until mitral valve opening. A measure of diastolic function
Time frame: 96 hours after operation until 6 months after operation
Ejection Fraction (Per Cent)
Transeosophageal echocardiography: Measure of systolic function
Time frame: End of operation until approx. 4 hours after operation
Isovolumetric Relaxation Time (IVRT) (s)
Transeosophageal echocardiography: Time from closure of aortic valve to opening of mitral valve. Measure of diastolic function.
Time frame: End of operation until approx. 4 hours after operation
Cardiac Index (l/Min/m2)
Invasive measurement measuring the cardiac output divided by calculated body surface area (DuBois formula)
Time frame: 1 hour before operation until start of operation
Cardiac Index (l/Min/m2)
Invasive measurement measuring the cardiac output divided by calculated body surface area (DuBois formula)
Time frame: Start of operation until end of operation, approximately 3 hours
Cardiac Index (l/Min/m2)
Invasive measurement measuring the cardiac output divided by calculated body surface area (DuBois formula)
Time frame: End of operation operation until approx. 4 hours after operation
Cardiac Index (l/Min/m2)
Invasive measurement measuring the cardiac output divided by calculated body surface area (DuBois formula)
Time frame: 4 hours after operation until 21 hours after operation
Inflammatory Parameters
Blood sample values of pro- and antiinflammatory mediators
Time frame: 4 hours before operation until 21 hours after operation
Inflammatory Parameters
Blood sample values of pro- and antiinflammatory mediators
Time frame: 21 hours after operation until 96 hours after operation
E/A-ratio (Transoesophageal)
Transoesophageal echocardiographic measure of diastolic heart function
Time frame: from start of operation until end of operation, approximately 3 hours
E/A-ratio (Transoesophageal)
Transoesophageal echocardiographic measure of diastolic heart function
Time frame: from end of operation until approximately 4 hours after operation
Urine Clearance
Urine analysis. Measure of kidney function.
Time frame: from start of operation until 24 hours after operation